Zevra Therapeutics (ZVRA) Long-Term Investments (2016 - 2026)
Zevra Therapeutics (ZVRA) posted Long-Term Investments of $36.1 million for Q1 2026, down 24.51% on a QoQ basis from $47.9 million in Q4 2025, and up 493.42% year-over-year from $6.1 million in Q1 2025.
Zevra Therapeutics (ZVRA) Long-Term Investments (2016 - 2026) Analysis & Trends
Zevra Therapeutics' Long-Term Investments history runs 7 years deep, the most recent figure standing at $36.1 million for Q1 2026.
- Quarterly Long-Term Investments rose 493.42% year-over-year to $36.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.1 million (up 493.42% YoY) and the FY2025 annual result came in at $47.9 million, up 696.66% from the prior year.
- Long-Term Investments was $36.1 million for Q1 2026 at Zevra Therapeutics, down from $47.9 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $47.9 million in Q4 2025 and bottomed at $6.0 million in Q4 2024.
- A 4-year average of $20.6 million and a median of $17.6 million in 2022 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments jumped 3981.63% — and 2025, when it jumped 405.57%.
- Zevra Therapeutics' Long-Term Investments stood at $20.0 million in 2022, then tumbled by 69.95% to $6.0 million in 2024, then soared by 696.66% to $47.9 million in 2025, then decreased by 24.51% to $36.1 million in 2026.
- Business Quant data shows ZVRA's Long-Term Investments at $36.1 million in Q1 2026, $47.9 million in Q4 2025, and $30.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn | 36.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.15 Mn |
| Dec 31, 2025 | 47.88 Mn |
| Sep 30, 2025 | 30.87 Mn |
| Jun 30, 2025 | 15.09 Mn |
| Mar 31, 2025 | 6.09 Mn |
| Dec 31, 2024 | 6.01 Mn |
| Sep 30, 2024 | 6.11 Mn |
| Dec 31, 2022 | 20.00 Mn |
| Mar 31, 2022 | 17.56 Mn |
| Dec 31, 2021 | 490,000.00 |
| Dec 31, 2017 | 3.25 Mn |
| Sep 30, 2017 | 6.72 Mn |
| Jun 30, 2017 | 11.22 Mn |
| Mar 31, 2017 | 10.16 Mn |
| Dec 31, 2016 | 8.20 Mn |
| Sep 30, 2016 | 27.36 Mn |
| Jun 30, 2016 | 18.85 Mn |